T1	Participants 103 148	acute bacterial maxillary sinusitis in adults
T2	Participants 159 185	multicentre, multinational
T3	Participants 229 323	outpatients with both clinical signs and symptoms and radiographic evidence of acute sinusitis
T4	Participants 501 552	452 patients considered valid for clinical efficacy
